Search - tctmd.com

Displaying 1 - 20 of 31

Sort: Relevancy | Date

News Daily News

Even With Optimized GDMT, HFrEF Prognosis Remains Dire

Michael O'Riordan

January 30, 2026

News Daily News

New Dietary Guidelines for Americans Get Mixed Review From Cardiology Community

Todd Neale

January 12, 2026

News Daily News

New ACC/AHA Hypertension Guidelines Still Urge Early Treatment but With Some Twists

Yael L. Maxwell

August 14, 2025

News Daily News

Medicaid Patients With Type 2 Diabetes Face Hurdles Getting Cardioprotective Meds

Michael O'Riordan

April 25, 2025

News Daily News

Only Small Minority of Eligible Patients Prescribed SGLT2 Inhibitors

Yael L. Maxwell

August 15, 2024

News Daily News

Acute HF Patients Live Longer When Seen by Specialists

Michael O'Riordan

August 09, 2024

News Daily News

AHA/ACC and Others Issue PAD Guideline Update With Focus on Collaborative Care

L.A. McKeown

May 17, 2024

News Conference News ACC 2024

Most HFrEF Patients Eligible for Quadruple Therapy, but Few Get It

Michael O'Riordan

March 27, 2024

News Daily News

AHA Updates Advice for Resuscitation, CV Care After Overdose or Poisons

L.A. McKeown

September 20, 2023

News Conference News ESC 2023

New ESC Guidelines for CVD in Patients With Diabetes Cover Wide Ground

Caitlin E. Cox

August 30, 2023

News Daily News

New Chronic Heart Disease Guidelines Update Roles of GDMT, Imaging, and Revascularization

Michael O'Riordan

July 20, 2023

News Daily News

New Expert Consensus Papers Aim to Boost Management, Outcomes in HFpEF

L.A. McKeown

April 19, 2023

News Daily News

Analysis Cements Benefits of SGLT2 Inhibitors in HF, but Diabetes Matters for Deaths

Michael O'Riordan

December 08, 2022

GDMT With ARNI Lessens MR, Perhaps Obviating Need for Interventions

News Conference News HFSA 2022

GDMT With ARNI Linked to Less MR, May Obviate Need for Interventions

Michael O'Riordan

October 04, 2022

News Conference News ESC 2022

CV Care Around Noncardiac Surgery: New ESC Guidelines

Michael O'Riordan

September 07, 2022

News Opinion Editor's Corner ESC 2022

What’s Going to Be Hot at ESC 2022?

Shelley Wood

August 22, 2022

News Daily News

USPSTF Recommends Behavior Counseling to Improve Diet and Exercise Habits

Michael O'Riordan

July 27, 2022

News Daily News

LVEF Analysis Digs Anew Into Revascularization Benefits in Ischemic CAD

Michael O'Riordan

July 11, 2022

News Conference News TVT 2022

Non-COAPT-Like Patients Fare Well With MitraClip, EXPAND Suggests

Michael O'Riordan

June 09, 2022

News Conference News ACC 2022

New HF Guidelines Stress Four-Drug Approach, ‘HFmrEF,’ Amyloidosis Options, and More

Shelley Wood

April 01, 2022

Advertisement

Even With Optimized GDMT, HFrEF Prognosis Remains Dire

New Dietary Guidelines for Americans Get Mixed Review From Cardiology Community

New ACC/AHA Hypertension Guidelines Still Urge Early Treatment but With Some Twists

Medicaid Patients With Type 2 Diabetes Face Hurdles Getting Cardioprotective Meds

Only Small Minority of Eligible Patients Prescribed SGLT2 Inhibitors

Acute HF Patients Live Longer When Seen by Specialists

AHA/ACC and Others Issue PAD Guideline Update With Focus on Collaborative Care

Most HFrEF Patients Eligible for Quadruple Therapy, but Few Get It

AHA Updates Advice for Resuscitation, CV Care After Overdose or Poisons

New ESC Guidelines for CVD in Patients With Diabetes Cover Wide Ground

New Chronic Heart Disease Guidelines Update Roles of GDMT, Imaging, and Revascularization

New Expert Consensus Papers Aim to Boost Management, Outcomes in HFpEF

Analysis Cements Benefits of SGLT2 Inhibitors in HF, but Diabetes Matters for Deaths

GDMT With ARNI Linked to Less MR, May Obviate Need for Interventions

CV Care Around Noncardiac Surgery: New ESC Guidelines

What’s Going to Be Hot at ESC 2022?

USPSTF Recommends Behavior Counseling to Improve Diet and Exercise Habits

LVEF Analysis Digs Anew Into Revascularization Benefits in Ischemic CAD

Non-COAPT-Like Patients Fare Well With MitraClip, EXPAND Suggests

New HF Guidelines Stress Four-Drug Approach, ‘HFmrEF,’ Amyloidosis Options, and More

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content